Wednesday, May 2, 2012

Holidays provide some of the best opportunities to get great photos, if you remember a few simple tips. Here?s professional photographer Nigel Barker of America?s Next Top Model, with great advice for getting the most out of every photo op.

smokey robinson pulmonary embolism packages camila alves albrecht durer dan marino david lee roth

Tuesday, May 1, 2012

First of its kind 'menopause map' helps women navigate treatment

First of its kind 'menopause map' helps women navigate treatment [ Back to EurekAlert! ] Public release date: 1-May-2012
[ | E-mail | Share Share ]

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380

Dionne Dougall-Bass
dionne@burnesscommunications.com
301-961-5803
Burness Communications

Nationwide Poll found 7 out of 10 women suffering from menopausal symptoms are not treated; Majority not talking to their doctors about various relief options

May 1, 2012 (Chevy Chase, MD) Women going through menopause now have a first-of-its-kind interactive guide to help them better understand their menu of treatment options, including whether hormone therapy may be right for them. The Endocrine Society and its Hormone Health Network today released the "Menopause Map," an online tool to help women and their doctors discuss which hormonal and non-hormonal treatment options would be most effective and safe to relieve the sometimes debilitating symptoms of menopause. A new accompanying survey found that the majority of women facing challenging symptoms are concerned about hormone treatment and are not discussing it, or other non-hormonal options, with their doctor. The Map was developed by Endocrine Society physician experts who specialize in menopause management.

The tool is based on the latest unbiased research and is intended to jumpstart conversations between women and their doctors about the choices available to them as they approach and experience menopause.

Hormone therapy has been under intense scrutiny since 2002, when a large government study called the Women's Health Initiative (WHI) reported that hormone therapyspecifically the combination of estrogen and progestin togetherincreased the risk for blood clots, stroke, breast cancer and heart attacks. The researchers halted the study and concluded that the risks of hormone therapy outweighed the benefits. Although the study was designed to evaluate the role of hormone therapy in the prevention of diseases related to aging, many women and their doctors also abandoned it as therapy for menopausal symptoms.

Over the past 10 years, additional research has found that the level of risk depends on the individual woman, her health history, age, and the number of years since her menopause began. In general, younger women (under 60) who have recently started menopause are at a lower risk than older women when taking low doses of hormone therapy.

"Left with the false impression that hormone therapy isn't a safe option, far too many women have suffered in silence thinking their options for symptom relief were limited or non-existent," says Cynthia Stuenkel, MD, a member of The Endocrine Society and an endocrinologist specializing in menopause at the University of California, San Diego. "We know that for some women, hormonal therapy provides the only relief for severe menopausal symptoms. Women deserve some clear answers and helpful tools to engage their doctors in meaningful conversations about the multiple choices available to improve their menopausal symptoms."

When a woman enters menopause, she stops menstruating and her body produces less of the sex hormones estrogen and progesterone. The process of menopause takes years. During that time, women may experience moderate to severe symptoms, including hot flashes, interrupted sleep, vaginal dryness, and other symptoms that affect her quality of life.

The survey found that 72 percent of women currently experiencing symptoms have not received any treatment for them. Other findings include:

  • Majorities of menopausal women experiencing symptoms have not talked to their primary health care provider or OB/GYN about hormone therapy (62%) or non-hormone options (61%), and half of them have not talked about lifestyle changes;
  • Nearly half (49%) of menopausal women experiencing symptoms have a negative impression of hormone therapy; and
  • While the sample sizes of African Americans and Latinas in the survey are small, only 17 percent of African-American respondents say they have talked to their doctors about hormone therapy, compared to 39 percent of white women and 35 percent of Latinas, suggesting that disparities may exist.

"Unfortunately, as in many health care issues, significant disparities exist. Add to that, many primary care doctors don't have enough information about the latest research or what to prescribe," Dr. Stuenkel says. "We want to make health care providers across the nation aware of this tool so that they can facilitate better discussions with their patients."

The "Menopause Map" is an online interactive tool that guides a woman through the different options available to get relief from her symptoms through a series of prompting questions about those symptoms and her personal health history. The Map also has links to questionnaires that help assess current risk for breast cancer, heart disease, and stroke. The tool weighs hormonal and non-hormonal therapies against the risks based on individual symptoms and medical history.

The Map was not designed to be a self-diagnostic tool. It's recommended that women print out their results along with a list of provided questions to discuss the best treatment options for them with their provider. Women should revisit this tool to check their symptoms and have a continuous, informed dialogue with their provider.

The important facts to know about hormone therapy are:

  • Women 60 years and older should not use menopausal hormone therapy.
  • Women 50-59 years or younger, with no family or personal history of breast cancer, no history of heart disease or stroke, and with moderate to severe menopausal symptoms are the best candidates for hormone therapy.
  • If considering hormone therapy, women should talk with their health care provider to determine a plan that is right for them.
  • In addition, lifestyle approach also helps alleviate symptoms and benefit long-term health.
  • For those who decide on hormone therapy, this is an ongoing process and might require a period of trial and error to find the right fit for each individual woman.
  • For those who decide on non-hormonal options, there are several proven therapies available that may help with symptoms. It is important women share information about all medications they are using, including over-the-counter drugs and nutritional supplements, to make sure the choice of therapy doesn't interact with other medications.

###

The Menopause Map can be found at www.hormone.org/MenopauseMap.

About the Survey: The Endocrine Society commissioned Lake Research Partners to conduct a nationally representative survey of 810 women ages 45-60 years old, April 13 -17, 2012. The margin of sampling error is + 4.3 percentage points.

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 15,000 physicians, scientists, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, MD. To learn more about the Society, and the field of endocrinology, visit our web site at www.endo-society.org.

The Hormone Health Network works to join Endocrine Society physicians, primary care providers, patients and the public in meaningful, informed discussions about hormones and health. The Network offers patients and their providers free, on-line resources that are based on the Society's most advanced clinical and scientific knowledge of endocrine-related diseases and conditions. Join the Hormone Health Network today by visiting www.hormone.org and subscribing to Hormone Hotline, our monthly e-update on hormones and health.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


First of its kind 'menopause map' helps women navigate treatment [ Back to EurekAlert! ] Public release date: 1-May-2012
[ | E-mail | Share Share ]

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380

Dionne Dougall-Bass
dionne@burnesscommunications.com
301-961-5803
Burness Communications

Nationwide Poll found 7 out of 10 women suffering from menopausal symptoms are not treated; Majority not talking to their doctors about various relief options

May 1, 2012 (Chevy Chase, MD) Women going through menopause now have a first-of-its-kind interactive guide to help them better understand their menu of treatment options, including whether hormone therapy may be right for them. The Endocrine Society and its Hormone Health Network today released the "Menopause Map," an online tool to help women and their doctors discuss which hormonal and non-hormonal treatment options would be most effective and safe to relieve the sometimes debilitating symptoms of menopause. A new accompanying survey found that the majority of women facing challenging symptoms are concerned about hormone treatment and are not discussing it, or other non-hormonal options, with their doctor. The Map was developed by Endocrine Society physician experts who specialize in menopause management.

The tool is based on the latest unbiased research and is intended to jumpstart conversations between women and their doctors about the choices available to them as they approach and experience menopause.

Hormone therapy has been under intense scrutiny since 2002, when a large government study called the Women's Health Initiative (WHI) reported that hormone therapyspecifically the combination of estrogen and progestin togetherincreased the risk for blood clots, stroke, breast cancer and heart attacks. The researchers halted the study and concluded that the risks of hormone therapy outweighed the benefits. Although the study was designed to evaluate the role of hormone therapy in the prevention of diseases related to aging, many women and their doctors also abandoned it as therapy for menopausal symptoms.

Over the past 10 years, additional research has found that the level of risk depends on the individual woman, her health history, age, and the number of years since her menopause began. In general, younger women (under 60) who have recently started menopause are at a lower risk than older women when taking low doses of hormone therapy.

"Left with the false impression that hormone therapy isn't a safe option, far too many women have suffered in silence thinking their options for symptom relief were limited or non-existent," says Cynthia Stuenkel, MD, a member of The Endocrine Society and an endocrinologist specializing in menopause at the University of California, San Diego. "We know that for some women, hormonal therapy provides the only relief for severe menopausal symptoms. Women deserve some clear answers and helpful tools to engage their doctors in meaningful conversations about the multiple choices available to improve their menopausal symptoms."

When a woman enters menopause, she stops menstruating and her body produces less of the sex hormones estrogen and progesterone. The process of menopause takes years. During that time, women may experience moderate to severe symptoms, including hot flashes, interrupted sleep, vaginal dryness, and other symptoms that affect her quality of life.

The survey found that 72 percent of women currently experiencing symptoms have not received any treatment for them. Other findings include:

  • Majorities of menopausal women experiencing symptoms have not talked to their primary health care provider or OB/GYN about hormone therapy (62%) or non-hormone options (61%), and half of them have not talked about lifestyle changes;
  • Nearly half (49%) of menopausal women experiencing symptoms have a negative impression of hormone therapy; and
  • While the sample sizes of African Americans and Latinas in the survey are small, only 17 percent of African-American respondents say they have talked to their doctors about hormone therapy, compared to 39 percent of white women and 35 percent of Latinas, suggesting that disparities may exist.

"Unfortunately, as in many health care issues, significant disparities exist. Add to that, many primary care doctors don't have enough information about the latest research or what to prescribe," Dr. Stuenkel says. "We want to make health care providers across the nation aware of this tool so that they can facilitate better discussions with their patients."

The "Menopause Map" is an online interactive tool that guides a woman through the different options available to get relief from her symptoms through a series of prompting questions about those symptoms and her personal health history. The Map also has links to questionnaires that help assess current risk for breast cancer, heart disease, and stroke. The tool weighs hormonal and non-hormonal therapies against the risks based on individual symptoms and medical history.

The Map was not designed to be a self-diagnostic tool. It's recommended that women print out their results along with a list of provided questions to discuss the best treatment options for them with their provider. Women should revisit this tool to check their symptoms and have a continuous, informed dialogue with their provider.

The important facts to know about hormone therapy are:

  • Women 60 years and older should not use menopausal hormone therapy.
  • Women 50-59 years or younger, with no family or personal history of breast cancer, no history of heart disease or stroke, and with moderate to severe menopausal symptoms are the best candidates for hormone therapy.
  • If considering hormone therapy, women should talk with their health care provider to determine a plan that is right for them.
  • In addition, lifestyle approach also helps alleviate symptoms and benefit long-term health.
  • For those who decide on hormone therapy, this is an ongoing process and might require a period of trial and error to find the right fit for each individual woman.
  • For those who decide on non-hormonal options, there are several proven therapies available that may help with symptoms. It is important women share information about all medications they are using, including over-the-counter drugs and nutritional supplements, to make sure the choice of therapy doesn't interact with other medications.

###

The Menopause Map can be found at www.hormone.org/MenopauseMap.

About the Survey: The Endocrine Society commissioned Lake Research Partners to conduct a nationally representative survey of 810 women ages 45-60 years old, April 13 -17, 2012. The margin of sampling error is + 4.3 percentage points.

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 15,000 physicians, scientists, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, MD. To learn more about the Society, and the field of endocrinology, visit our web site at www.endo-society.org.

The Hormone Health Network works to join Endocrine Society physicians, primary care providers, patients and the public in meaningful, informed discussions about hormones and health. The Network offers patients and their providers free, on-line resources that are based on the Society's most advanced clinical and scientific knowledge of endocrine-related diseases and conditions. Join the Hormone Health Network today by visiting www.hormone.org and subscribing to Hormone Hotline, our monthly e-update on hormones and health.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


craig smith eat to live eat to live ron paul money bomb ron paul money bomb bon vivant zynga ipo

Coke denies thirst for Monster energy drink

CNBC's Darren Rovell reports on beverage stocks, including shares of Monster Beverage Corporation moving higher on an alleged acquisition by Coca-Cola.

By msnbc.com news reports

Updated 1:37 p.m. ET: Coca-Cola said it is not in talks to buy Monster Beverage Corp., disputing a Wall Street Journal article to the contrary. Monster shares (MNST) surged more than 25 percent after the report on the Journal's website before plunging back to Earth to close the day with a loss.

"At this time, we are not in discussions to acquire the Monster Beverage Corp. Coke said in a statement issued after the market close. "We continue to review the best ways to maximize the value of our relationship."

Shares of Coke (KO) were little changed on the day.

An acquisition of Monster, which has a market capitalization of more than $11 billion, would be the largest brand acquisition for Coca-Cola, according to the paper.

Coca-Cola already has a energy drink brand -- Full Throttle -- but sales have been disappointing. Red Bull and Monster are the market leaders in the market targeted heavily to a younger demographic.

According to the Wall Street Journal report:

... [T]he energy-drinks company is also seen as expensive since its stock price has almost doubled in the last year, people familiar with the matter said. Monster trades at roughly 30 times estimated 2012 earnings, which analysts consider expensive. Its shares hit a new 52-week high last week.

As a result, Coca-Cola may ultimately decide that Monster Beverage's price is too high for a deal, people familiar with the matter said. Coca-Cola already has an agreement with Monster to distribute some of its drinks, and that could diminish the potential synergies from any deal?and thus its willingness to pay a large premium for the company.

A Monster spokeswoman said it is the company's policy not to comment on rumors.

Coke and Monster had held talks last year that did not result in a transaction, according to the Journal, which cited?two sources familiar with the situation.

Reuters contributed to this report.??

packers giants game golden globe winners 2012 ricky gervais golden globes epidermolysis bullosa miss wisconsin law abiding citizen golden globes 2012

Nightclub scraps live zebra plan

A nightclub manager said he has been forced to cancel plans to hire a live zebra after complaints from animal welfare groups.

Carbon bar had printed posters promising a zebra at its Zoo club night as a "first" for the Oxford club scene.

Manager Jan Zarecky said it had been planned as "a bit of fun".

The RSPCA spokeswoman said it had worries the zebra's safety would be "unnecessarily compromised for the purpose of entertainment."

"If the Zebra was to be kept outside a noisy nightclub we would be very concerned," she added.

'Serengeti scene'

Mr Zarecky said the animal had been booked from an animal acting agency.

"It wasn't ever meant to cause anyone offence. It purely was a bit of fun. The zebra was going to go out in front of the building. We were planning to build a pen made from crowd barriers and decorated with bamboo to set a Serengeti scene."

He said he was "massively surprised" by the amount of opposition from animal rights groups.

Comments were also posted on the social networking sites Facebook and Twitter.

One said: "Would those who support it take their own pets to stand outside the nightclub ahead of a queue of loud, possibly drunken revellers? Not really the place for any animal."

Oxfordshire County Council Trading Standards confirmed it had discussed the idea with the club but said its officers had "reservations" about the proposal.

The club's application for a Performing Animals Licence was withdrawn before it was considered by council officials.

Mr Zarecky said he was not going to rule out hiring animals in future but that next time the club would do things differently.

He added "I'm open to anything that's legal and accepted by society as a whole."

csco big bend national park leon russell meredith vieira prop 8 larry bird maria menounos

[WATCH]: How to sell on eBay - How to Earn a Living Online

Posted on April 30th, 2012 in eBay

Rating: 4

www.BiddingBuzz.com.au Trying to sell on eBay just by reading an eBay book can be dangerous to your bank account, if you don?t get the right information. Too many people risk making big mistakes which could otherwise have been avoided if they had invested more time in finding the right ebay program initially. Bidding Buzz are the worlds leading eBay educators and have helped hundreds of people make amazing eBay businesses. Their programs come with audio CD?s, DVD?s online eLessons, manuals and screen capture videos. Find out more but don?t try to short cut the process with just an eBay book. work at home work from home make cash earn cash make money on line internet money making easy making money way making money ideas internet businesses business on internet starting internet business online business opportunity businesses opportunities Learn more at www.BiddingBuzz.com.au

Tags: amanda, Book, business, ebay, how, matt, mattandamanda, People, sell, selling

geithner gabrielle giffords juliette lewis chelsea handler mitch daniels elizabeth warren shirataki noodles